Delivery Order SPE2DB22D2214-SPE2DB25FS5WE
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,116.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for LINZESS 145 microgram capsules (30-count unit of use packaging) on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-competitive delivery order is issued under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,466.94 to AmerisourceBergen Drug Corp for LINZESS 72 MCG capsules (30-count unit) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. LINZESS is a prescription medication used to treat irritable bowel syndrome with...
- The Defense Logistics Agency awarded a $4,291.87 delivery order to AmerisourceBergen Drug Corp for LINZESS 145 MCG capsules (30-count unit of use packaging) on April 24, 2025, with completion scheduled for April 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LINZESS 145 MCG capsules (30-count units) on August 6, 2025, with a ceiling value of $5,326.68. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,392.69 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Linzess 290 microgram capsules (30-count unit dose). This is a firm fixed price, competitive delivery order with no set-aside designation and an ultimate completion date of August 11, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,333.53 to AmerisourceBergen Drug Corp for Linzess 72 mcg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible vendors in the open market. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Linzess 145 MCG capsules in a quantity of 30 units, with a ceiling value of $3,266.83 and a firm fixed price structure. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by July 30, 2025. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a $3,706.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Linzess 72 microgram capsules (30-count units) on May 27, 2025, with completion expected by May 28, 2025. This is a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,826.43 for Linzess 290 microgram capsules (30-count unit of use packaging) on July 8, 2025, with completion targeted for July 9, 2025. This firm fixed-price delivery order, processed without set-aside designation, represents a competitively awarded transaction fulfilling pharmaceutical supply requirements for military and federal healthcare systems. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $20,281.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LINZESS 145 MCG capsules (30-count units) with an ultimate completion date of August 18, 2025. This non-set-aside competitive award was issued on August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...